$LUCY

Gross Harrison R. sold $24K of LUCY

Gross Harrison R. (Chief Executive Officer) sold 27,738 shares of Innovative Eyewear Inc (LUCY) at an average of $0.88 ($0.69–$1.07) across 3 trades over 2026-04-02 to 2026-08-19.

Original reporting
SEC EDGAR · Gross Harrison R.
Published Aug 24, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LUCY
Bearish
medium confidence
Mentioned
$LUCY
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LUCYBearishLow
01

Why it matters

The disclosed sale is small relative to the company's market cap, suggesting limited market impact.

02

Market read

Minor insider sell; unlikely to move the stock significantly.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 3/10Novelty 4/10Timing: filed today (2026-08-24)

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$LUCYBearishMedium confidence
Context

CEO Gross Harrison R. sold 27,738 shares for $24.4K in a Form 4 filing.

Expected impact

Negligible impact; price may dip slightly on volume.

Evidence & confidence

The transaction size is modest ($24K) and represents a minor portion of holdings.

Market effects

None; eyewear sector unchanged.

No regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity move, not a signal of weakness.

Key entities

  • Innovative Eyewear Inc

    Issuer of the stock (ticker LUCY).

  • Gross Harrison R.

    Chief Executive Officer and insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.